ÂÜÀòÂÒÂ×

Nick Birringer is an accomplished professional in the pharmaceutical industry, currently serving as Senior Director of Drug Product at BridgeBio since November 2019, and also maintaining a Director role at Eidos Therapeutics. Previous experience includes Director of CMC at Soleno Therapeutics, Director of Drug Product at Aimmune Therapeutics, and various positions at Gilead Sciences, Colorcon, and Merck. Nick Birringer's educational background is grounded in a degree from Purdue University, obtained between 1999 and 2003.